Melasma is a common skin condition characterized by hyperpigmentation caused by increased melanin production in the dermis and epidermis layers. One of the main reasons melasma does not improve with typical treatments is the persistence of tyrosinase enzyme activity, which stimulates melanin synthesis. Effective melasma treatments frequently include ingredients that inhibit tyrosinase to reduce pigmentation. The product mentioned, POND'S Clarants B3, contains key components designed to combat hyperpigmentation by targeting the underlying cause: excess melanin production. The use of niacinamide (Vitamin B3) in such formulations can reduce the transfer of melanin to skin cells, provide anti-inflammatory benefits, and improve skin tone. In addition to topical treatments, managing melasma requires consistent sun protection since UV exposure worsens pigmentation. Incorporating broad-spectrum sunscreen and avoiding prolonged sun exposure are critical. Moreover, factors like hormonal imbalances and genetics also affect melasma persistence. Consulting a dermatologist can provide personalized treatment options, such as chemical peels or laser therapy, suited to individual skin types. Maintaining a consistent skincare routine that includes gentle cleansing, moisturizing, and targeted treatment products can improve results. It is essential to have patience since melasma may take several weeks or months to show noticeable improvement. Repeated use of trusted skincare products such as the POND’S Clarants line, combined with lifestyle adjustments, offers a comprehensive approach to managing melasma and achieving a brighter, more even complexion.